1. Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature
- Author
-
Paola Tatarelli, Marina Gramiccia, Claudio Viscoli, V. Del Bono, Malgorzata Mikulska, A M Raiola, T. Di Muccio, Luigi Gradoni, Emanuele Angelucci, Laura Ambra Nicolini, Riccardo Varaldo, Francesca Gualandi, and G. Fornaro
- Subjects
Male ,Opportunistic infection ,Pancytopenia ,medicine.medical_treatment ,Antibodies, Protozoan ,0302 clinical medicine ,Fatal Outcome ,immune system diseases ,Recurrence ,hemic and lymphatic diseases ,Pharmacology (medical) ,030212 general & internal medicine ,Visceral leishmaniasis ,Leishmania ,Hematopoietic cell transplantation ,biology ,medicine.diagnostic_test ,Hematopoietic Stem Cell Transplantation ,Bone Marrow Examination ,Middle Aged ,Hodgkin Disease ,medicine.anatomical_structure ,Infectious Diseases ,Leishmaniasis, Visceral ,Female ,Microbiology (medical) ,Adult ,medicine.medical_specialty ,Fever ,030231 tropical medicine ,Antiprotozoal Agents ,Antineoplastic Agents ,Opportunistic Infections ,03 medical and health sciences ,Internal medicine ,Amphotericin B ,medicine ,Humans ,Bone marrow ,Chemotherapy ,business.industry ,Leishmania spp ,Bone marrow, Fever, Hematopoietic cell transplantation, Leishmania spp., Pancytopenia, Visceral leishmaniasis, Microbiology (medical), Pharmacology (medical), Infectious Diseases ,medicine.disease ,biology.organism_classification ,Transplantation ,Bone marrow examination ,business - Abstract
Visceral leishmaniasis has been recognized as an opportunistic infection affecting people with cellular-immunity impairment, including hematopoietic cell transplantation (HCT) recipients. We describe the case of a young Italian man with Hodgkin lymphoma, who developed visceral leishmaniasis after multiple lines of chemotherapy and allogenic HCT. Literature review of visceral leishmaniasis in HCT recipients was also performed. Eleven patients (median age 50 years, 9 male) developed visceral leishmaniasis after allogenic (n = 9) and autologous (n = 2) HCT. Most of them presented with fever and pancytopenia. Bone marrow examination was the main diagnostic technique; liposomal amphotericin B was the treatment of choice. Four out of eight patients (for whom data are available) experienced visceral leishmaniasis relapse. Visceral leishmaniasis in HCT recipients is a rare event that should be suspected in patients with persistent fever, pancytopenia and possible exposure to Leishmania spp., remembering that – as well as South-East Asia, East Africa and South America - it is endemic in several European regions.
- Published
- 2018